In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AutoGenomics Inc.

www.autogenomics.com

Latest From AutoGenomics Inc.

Studies Find Limited Support For Genotyping-Guided Warfarin Dosing

The overall message of three trials published recently in The New England Journal of Medicine: “This pharmacogenetic testing has either no usefulness in the initial dosing of vitamin K antagonists or, at best, marginal usefulness, given the cost and effort required to perform this testing,” according to an editorial also in NEJM.

Medical Device Clinical Trials

Device/Diagnostics Quarterly Deal Statistics, Q3 2012

Device companies raised a total of $801 million in 2012’s third quarter, an 18% drop from Q2’s $977 million. Approximately $2.6 billion was spent on device acquisitions, exactly $2 billion less than Q2’s total. Diagnostic/research company financings totaled $484 million during Q3 2012, up from last quarter’s $336 million. And while diagnostic/research M&A activity was not as prolific as last quarter, tech transfer deals are seeing a resurgence.

Medical Device Deals

Deals Shaping The Medical Industry, November 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device

Medical Device Deals Update, October 2012

A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Nanotechnology, Chips, etc.
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Medical Devices
    • Consumables, Central Supplies
    • Diagnostic Equipment & Supplies
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Cardiovascular
  • Gynecological, Urological
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • AutoGenomics Inc.
  • Senior Management
  • Fareed Kureshy, Chmn., Pres. & CEO
    Thomas V Hennessey, COO & CFO
    Ram Vairavan, VP, Sales & Mktg.
    Patrick J Dillon, PhD, CSO
    Saeed Kureshy, VP, Operations
  • Contact Info
  • AutoGenomics Inc.
    Phone: (760) 477-2251
    2980 Scott St.
    Vista, CA 92081
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register